Item 3.01. | Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. |
On December 1, 2023, NiSource Inc. (the “Company”) issued a press release announcing, among other things that, pursuant to the terms of its Series A Corporate Units, originally issued on April 19, 2021, it intends to voluntarily delist its Series A Corporate Units from the New York Stock Exchange (“NYSE”).
The Company currently anticipates a Form 25 will be filed with the Securities and Exchange Commission relating to the delisting on December 1, 2023, and that the delisting of its securities will become effective on December 1, 2023. The Company does not expect that the delisting will have any adverse effects on the continued listing of the Company’s Common Stock and the Company will remain subject to the periodic reporting requirements of the Securities Exchange Act of 1934, as amended.
Item 7.01. | Regulation FD Disclosure. |
On December 1, 2023, the Company issued a press release announcing, among other things, the settlement rate of the purchase contracts that form part of its Series A Corporate Units, originally issued on April 19, 2021 as part of the Company’s equity units.
A copy of the press release is attached as Exhibit 99.1 and the information set forth therein is incorporated herein by reference and constitutes a part of this report. The information included in this Item 7.01 of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 are for informational purposes only and do not constitute an offer to sell the Mandatory Convertible Preferred Stock.
The information set forth in and incorporated by reference into this Item 7.01 (including Exhibit 99.1) of this Current Report on Form 8-K is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits